2024-11-08  9:59:55 PM Chg. -0.51 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
108.19USD -0.46% 123,326
Turnover: 13.39 mill.
-Bid Size: - -Ask Size: - 21.54 bill.USD 0.89% 22.03

Business description

Founded in 1927 and headquartered in Warsaw, Indiana, USA, Zimmer Biomet is a global leader in musculoskeletal healthcare. The company designs, manufactures and markets orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
 

Management board & Supervisory board

CEO
Ivan Tornos
Management board
Suketu Upadhyay, Mark Bezjak, Rachel Ellingson, Nitin Goyal, David J. Kunz, Angela Main, Keri P. Mattox, Chad Phipps, Paul Stellato, Zeeshan Tariq, Kenneth R. Tripp, Lori Winkler, Sang Yi, Wilfred van Zuilen
Supervisory board
Christopher B. Begley, Betsy J. Bernard, Michael J. Farrell, Robert A. Hagemann, Ivan Tornos, Arthur J. Higgins, Maria Teresa Hilado, Syed Jafry, Sreelakshmi Kolli, Michael W. Michelson
 

Company data

Name: Zimmer Biomet Holdings Inc.
Address: 345 East Main Street,Warsaw, Indiana 46580, USA
Phone: +1-574-373-3121
Fax: -
E-mail: surveys@zimmerbiomet.com
Internet: www.zimmerbiomet.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12-31
Free Float: 74.90%
IPO date: 2001-08-03

Investor relations

Name: Zach Weiner
IR phone: +1-908-591-6955
IR Fax: -
IR e-mail: Zach.Weiner@ZimmerBiomet.com

Main Shareholders

Others
 
52.20%
Vanguard Group Inc
 
11.59%
BlackRock Inc.
 
9.09%
Dodge & Cox
 
5.57%
Price T Rowe Associates Inc Md
 
4.58%
State Street Corporation
 
4.52%
Invesco Ltd.
 
3.01%
American Century Companies Inc
 
2.88%
Primecap Management Co Ca
 
2.47%
Others
 
4.09%